abstract |
The present invention relates to a prodrug of the cdc25B gene, and to a method for the preparation of a prodrug of cdc25B and to the preparation of a pharmaceutical composition for use in a prodrug. The killing of the present invention is useful in the gene therapy treatment and prevention of needlestick, inflammatory, circulatory, hematopoietic, hormone, infectious and immune system diseases. ŕ |